Latest Leadership Changes News

Reece Limited reported a modest revenue decline and earnings pressure in FY25 amid challenging markets but reinforced its long-term growth strategy with a significant share buyback and board renewal. Early FY26 trading shows sales growth driven by network expansion despite ongoing cost pressures.

Golden State Mining has completed a $1.5 million placement at 0.8 cents per share, appointed Keith Middleton as Managing Director, and launched a strategic review of its gold projects in Western Australia.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.

Close the Loop Limited reports stronger Q1 FY26 revenue and EBITDA, boosted by strategic asset sales and operational improvements, while navigating key board and CFO departures.

Emu NL announces the departure of CEO Adrian Griffin and the appointment of Non-Executive Director Peter Swiridiuk as interim CEO, signaling a leadership transition at the mining explorer.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

Growthpoint Properties Australia reported a robust FY25 with funds from operations exceeding guidance, expanded funds management assets, and achieved its Net Zero emissions target ahead of schedule. The company reaffirmed positive FY26 outlook amid leadership changes and ongoing sustainability commitments.

Ava Risk Group announces the upcoming retirement of CEO Mal Maginnis, with senior executive Neville Joyce appointed as Acting CEO. The company embarks on a global search for a permanent replacement amid strong recent growth.

Qube Holdings reported a robust FY25 with significant revenue and earnings growth, strategic acquisitions, and a refreshed board leadership. Despite operational challenges, the company raised its dividend and confirmed solid FY26 earnings guidance.

Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.

Worley Limited reported solid financial results for FY2025, highlighted by disciplined capital management including a $269 million share buy-back and a strong focus on sustainability. The company outlined strategic priorities and anticipates moderate growth in FY2026 with a new growth strategy to be revealed next year.

ParagonCare reported solid FY25 results, progressing well on its complex merger integration and expanding its footprint in Asia through the acquisition of Somnotec Group.